U.S. Securities and Exchange Commission
                             Washington, D.C. 20549

                                   Form 10-QSB/A

(Mark One)

[X]  QUARTERLY  REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES  EXCHANGE ACT
     OF 1934 For the period ended April 30, 2000
                                  --------------

[    ] TRANSITION  REPORT UNDER SECTION 13 OR 15(d) OF THE  SECURITIES  EXCHANGE
     ACT  OF  1934  [No  Fee  Required]  For  the  transition   period
     from        to
          ------   ------


                         Commission File number 0-21019


                           INNOVATIVE MEDICAL SERVICES
                           ---------------------------
                 (Name of small business issuer in its charter)


                California                            33-0530289
          -------------------------------------------------------------------
          (State or other jurisdiction
         of incorporation or organization)  (IRS Employer Identification No.)



                    1725 Gillespie Way, El Cajon, California 92020
                -------------------------------------------------------
                    (Address of principal executive offices)


                                  619 596 8600
                            -------------------------
                            Issuer's telephone number

         Check  whether  the issuer (1) filed all reports to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days. Yes X No

         State the number of shares  outstanding of each of the issuer's classes
of common  equity as of the latest  practicable  date:  6,443,814  as of June 8,
2000.







<PAGE>

                       Text of the Amendment

Explanatory note:

Each of the above  listed  items is hereby  amended by deleting  the item in its
entirety and replacing it with the items attached hereto and filed herewith.

The purpose of this  amendment is to amend the  Company's  10-QSB for the period
ending April 30, 2000 (the "Original Filing").

During the period from January 1999 to January 2000, the Company's  Research and
Development  Department  created  an  e-commerce  web  supersite.  The  costs of
development  during this period were expensed as incurred.  According to SOP98-1
(Statement of Position issued by the Accounting  Standards Executive  Committee)
these costs should have been  capitalized and included in the Company's  assets.
The Company had identified $450,100 of costs associated with the construction of
the  website   during  this   period.   As  the  software   neared   completion,
Nutripure.com,  a wholly owned subsidiary of the Company,  was formed to acquire
and operate the website.  The website was sold to Nutripure.com  for $1,000,000.
In order  to  correct  not  previously  capitalizing  the  costs of the  website
development, the Company accounted for this transaction by capitalizing $115,300
of the identified  costs that occurred in the current quarter and by eliminating
from inter-company sales $665,200,  and with the remaining $334,800 representing
the costs not capitalized in previous quarters,  increased revenues and earnings
for the period.

The  accompanying  restated  consolidated  financial  statements   retroactively
reflect a lowered amount of $207,707 of website cost. These reduced costs, which
represent  only those  expenses  directly  related to website  development,  are
consistent with the newly issued EITF Issue No. 00-2 -Emerging Issues Task Force
Issue Titled: Accounting for Web Site Development Costs dated March 16, 2000. Of
this amount, $79,900 was incurred before the beginning of the fiscal year and is
shown as a cumulative  change in  accounting  principle.  At the same time,  the
entire  $1,000,000 is eliminated  from  inter-company  sales to correctly  state
total revenues.

The  accompanying  financial  statements also reflect an increase of $130,000 in
General and  Administrative  Expenses  that  represents  an addition to bad debt
expense for a receivable that is now considered a doubtful account.

As a result, sales decreased $334,800 from $1,909,600 to $1,574,800 for the nine
months  ended  April 30,  2000.  At the same time,  General  and  Administrative
Expenses  decreased  by $28,500 of website  expense  and by $130,000 of bad debt
expense for a total of $101,500.  The cumulative change in accounting  principle
resulted in a net gain of $79,900.  Net loss increased $359,600 from $474,900 to
$834,500 for the nine months ended April 30, 2000.  Net loss  decreased  $13,200
from  $662,300  to  $649,100  for the  quarter  ended April 30, 2000 due to less
amortization on the lower capitalized amount of the website.

<PAGE>


<TABLE>
<CAPTION>


CONSOLIDATED BALANCE SHEETS
------------------------------------------------------------------------------------------------
                                                                (Unaudited)
                                                                 April 30           July 31
ASSETS                                                             2000               1999
                                                              ---------------    ---------------
Current Assets
<S>                                                              <C>                   <C>
     Cash and cash equivalents                                   $ 1,413,219           $ 22,056
     Restricted cash                                                 200,962            205,574
     Accounts receivable, net of allowance for doubtful
         accounts of $ 180,000                                     1,014,104            790,166
     Notes receivable                                                216,647            339,524
     Inventories                                                     712,214            719,972
     Prepaid expenses                                                 59,153             37,078
                                                                     -------             ------

         Total current assets                                      3,616,299          2,114,370
                                                                  ----------          ---------

Property, Plant and Equipment
     Property, plant and equipment                                 1,010,900            805,523
                                                                  ----------            -------

         Total property, plant and equipment                       1,010,900            805,523
                                                                  ----------            -------

Noncurrent Assets
     Deposits                                                         13,083              6,575
     Patents and license                                             576,016            425,550
     Goodwill                                                        252,522            256,422
     Other intangible assets                                         346,500            353,250
     Deferred acquisition costs                                      103,376             53,851
                                                                    --------            ------

         Total noncurrent assets                                   1,291,498          1,095,648
                                                                  ----------          ---------

     Total assets                                                $ 5,918,696        $ 4,015,541
                                                                ============        ===========

LIABILITIES AND STOCKHOLDERS EQUITY
Current Liabilities
     Accounts payable                                              $ 321,961          $ 594,948
     Accrued liabilities                                              55,709             43,068
     Notes payable                                                   260,411            446,067
                                                                    --------            -------

         Total current liabilities                                   638,082          1,084,083
                                                                    --------          ---------

Minority interest payable                                             75,082                  -
                                                                    --------              -----
Stockholders' Equity
     Class A common stock, no par value: authorized
          20,000,000 shares, issued and outstanding
         6,416,939 at April 30, 2000 and
         4,392,242 at July 31, 1999                                9,771,973          6,663,318
     Class A warrants: issued and outstanding 3,687,500
         warrants                                                    108,750            108,750
     Accumulated deficit                                          (4,675,190)        (3,840,610)
                                                                  -----------        -----------

         Total stockholders' equity                                5,205,533          2,931,458
                                                                ============        ===========

     Total liabilities and stockholders' equity                 $  5,918,696        $ 4,015,541
                                                                ============        ===========
</TABLE>



<PAGE>




<TABLE>
<CAPTION>

STATEMENT OF INCOME (Unaudited)
------------------------------------------------------------------------------------------------
                                          For the Nine Months Ended   For the Three Months Ended
                                                 April 30                    April 30
                                            2000          1999          2000          1999
                                         -----------   -----------     ---------   ------------
<S>                                      <C>           <C>             <C>          <C>
Net sales                                $ 1,574,840   $ 2,733,401     $ 357,845    $ 1,169,903
Cost of sales                                809,301     1,050,880       234,249        496,960
                                            --------    ----------      --------       -------

Gross profit                                 765,539     1,682,521       123,596        672,943
                                            --------    ----------      --------        -------

Selling expenses                             406,377       289,028       147,947        101,256
General and administrative expenses        1,219,428       790,669       612,652        342,964
Research and development                      84,496       119,862        40,380         34,923
                                             -------      --------       -------         ------
                                                   -
Total operating costs                      1,710,301     1,199,559       800,979        479,143
                                          ----------    ----------      --------        -------

Operating income (loss)                     (944,762)      482,962      (677,383)       193,800
                                            ---------     --------      ---------       -------

Other income and (expense):
Interest income                                4,218         8,097         1,714          2,716
                                              ------        ------        ------          -----

Total other income (expense)                   4,218         8,097         1,714          2,716
                                              ------        ------        ------          -----

Income (loss) before income taxes, minority
    Interest in subsidiary operations and
    change in accounting principle          (940,544)      491,059      (675,669)       196,516

Federal and state income taxes                   600           600           200            200
                                                ----          ----          ----            ---

Income (loss) before minority interest in subsidiary
    operations and change in
    accounting principle                    (941,144)      490,459      (675,869)       196,316

Minority interest in subsidiary operations    26,718             -        26,718              -
                                             -------            --       -------             --

Net income (loss) before cumulative
    change in accounting principle          (914,427)      490,459      (649,151)       196,316

Cumulative effect (to August 31, 1999) of change
    in accounting principle
   (see explanatory note)                     79,896             -             -              -
                                             -------            --            --             --

Net income (loss)                         $ (834,531)   $  490,459    $ (649,151)    $  196,316
                                          ===========   ==========    ===========    ==========


Net income (loss) per common share before change
    in accounting principal (basic)            (0.17)         0.07         (0.12)          0.04
Cumulative effect (to August 31, 1999) of change
    in accounting principle
   (see explanatory note)                       0.01             -             -              -
                                               -----       -------        ------         ------
Net income (loss) per common share (basic)   $ (0.16)      $  0.07         (0.12)        $ 0.04
                                             ========      =======        ======         ======

Net income (loss) per common share before change
    in accounting principal (diluted)          (0.11)         0.04         (0.08)          0.02
Cumulative effect (to August 31, 1999) of change
    in accounting principle
   (see explanatory note)                       0.01             -             -              -
                                               -----       -------       -------        -------
Net income (loss) per common share (diluted) $ (0.10)      $  0.04        $(0.08)       $  0.02
                                             ========      =======       ========       =======
</TABLE>


<TABLE>
<CAPTION>

                                                                      Nine Months
                                                                        Ended       Year Ended
                                                                      April 30    Ended July 31
CONSOLIDATED STATEMENTS OF ACCUMULATED DEFICITS                         2000          1999
-----------------------------------------------------------------------------------------------

<S>                                                                 <C>            <C>
Balance, beginning of period                                        $ (3,840,610)  $ (4,101,330)

Net income (loss)                                                       (834,531)       260,720
                                                                        ---------       -------

Balance, end of period                                              $ (4,675,191)  $ (3,840,610)
                                                                    =============  =============
</TABLE>


<PAGE>

<TABLE>
<CAPTION>

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

                                                                         For the Nine Months Ended
                                                                                  April 30
                                                                         2000                1999
                                                                     ------------     ------------
Cash flows from operating activities
<S>                                                                   <C>               <C>
   Net income (loss)                                                  $ (834,531)       $ 490,459

   Adjustments to reconcile net income to net cash
   provided by operating activities:
       Depreciation                                                      115,324          116,189
       Minority interest in subsidiary operations                         75,082
   Changes in assets and liabilities:
       (Increase) decrease in restricted cash                              4,613          101,425
       (Increase) decrease in accounts receivable                       (223,938)      (1,021,065)
       (Increase) decrease in notes receivable                           122,877          (83,399)
       (Increase) decrease in prepaid expense                              7,758           (1,080)
       (Increase) decrease in inventory                                  (22,075)         (62,095)
       (Increase) decrease in deposits                                    (6,508)          (4,450)
       (Increase) decrease in patent and licenses                       (150,465)        (367,140)
       (Increase) decrease in goodwill                                     6,750         (258,055)
       (Increase) decrease in intangible assets                          (49,525)        (355,500)
       (Increase) decrease in deferred acquisition costs                       -        1,051,422
       Increase (decrease) in accounts payable                          (272,987)         (71,054)
       Increase (decrease) in accrued liabilities                         12,641          (43,928)
                                                                    -------------     ------------

            Net cash provided (used) by operating
                  activities                                          (1,214,985)        (508,272)
                                                                    -------------     ------------

Cash flows from investing activities
   Purchase of property, plant and equipment                            (316,851)        (120,817)
                                                                                      ------------

            Net cash (used) in investing activities                     (316,851)        (120,817)
                                                                  ---------------     ------------

Cash flows from financing activities
   Increase (decrease) in notes payable                                 (185,656)         361,172
   Proceeds from sale of common stock                                  3,108,655          375,238
                                                                  ---------------     ------------

            Net cash provided by financing activities                  2,923,000          736,410
                                                                  ---------------     ------------

            Net increase (decrease) in cash and cash
                  equivalents                                          1,391,163          107,320

Cash at beginning of period                                               22,056           48,250
                                                                  ---------------     ------------

Cash at end of period                                                $ 1,413,219        $ 155,570
                                                                  ==============        =========

Interest paid                                                        $    65,286        $  39,622
Taxes paid                                                           $       600        $     600
</TABLE>



<PAGE>
SIGNATURES
Pursuant  to the  requirement  of the  Securities  Exchange  Act  of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


INNOVATIVE MEDICAL SERVICES
(Registrant)

By: /s  Michael L. Krall
------------------------
Michael L. Krall, President/CEO
Date:  October 20, 2000


By: /s/ Gary Brownell
---------------------
Gary Brownell, Chief Financial Officer
Date:  October 20, 2000

<PAGE>